George Vlahos - Concepedia

Author

George Vlahos

National and Kapodistrian University of Athens

Also Known As

G Vlahos, G. Vlahos, George Vlahos

Publications

870

Citations

H-Index

Concepts

All Affiliations

National and Kapodistrian University of Athens Alexandra Hospital Therapeutics Clinical Research

About

George Vlahos is an author at National and Kapodistrian University of Athens specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	516
2	Public Health	2	2	80
3	Health Sciences	1	1	20
4	Cell Biology	1	1	162
5	Hepatology	1	1	20

George Vlahos

Publications

821

Citations

H-Index

Page 1

	Year	Citations
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals <i>via</i> VEGF receptor Type 2 Apostolos C Ziogas, Nikos G. Gavalas, Marinos Tsiatas, International Journal of Cancer Healthy IndividualsT-regulatory CellImmunologyVegf ReceptorT Cells	2011	162
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2 N. Gavalas, Marinos Tsiatas, Ourania Tsitsilonis, British Journal of Cancer	2012	161
Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy Aristotelis Bamias, Vasiliki Koutsoukou, Evangelos Terpos, Gynecologic Oncology Platinum ResistanceCancer ImmunosurveillanceMalignant DiseaseMedicineImmunology	2007	92
Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum‐paclitaxel chemotherapy Aristotle Bamias, Maria Sotiropoulou, Dimitrios Haidopoulos, Cancer	2010	88
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance Aristotelis Bamias, Marinos Tsiatas, Eftychia Kafantari, Gynecologic Oncology Hematological MalignancyPlatinum ResistanceTumoral PathologyMedicineImmunology	2007	76
Conservative Management of Cervical Intraepithelial Neoplasia (CIN<sub>2–3</sub>) in Pregnant Women George Vlahos, Alexandros Rodolakis, E Diakomanolis, Gynecologic and Obstetric Investigation Cervical Intraepithelial NeoplasiaCervical Cancer ManagementGynecological SurgeryCervical CancerCervical Health	2002	57
Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: Cell type is the most useful prognostic factor Aristotelis Bamias, Maria Sotiropoulou, Flora Zagouri, European Journal of Cancer Prognostic EvaluationSurgical OncologyTumoral PathologyMedicineTumour Type	2011	49
The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy Efstathios Kastritis, Aristotle Bamias, George Bozas, Gynecologic Oncology Cervical Cancer ManagementCervical CancerMedicineCancer RecurrenceCancer Management	2006	23
Young Age Is Associated with Favorable Characteristics but Is Not an Independent Prognostic Factor in Patients with Epithelial Ovarian Cancer: A Single Institution Experience George Bozas, Meletios Α. Dimopoulos, Efstathios Kastritis, Oncology	2006	23
Clinical Significance of Hepatitis B Surface Antigen in Cord Blood of Hepatitis B e-Antigen-Negative Chronic Hepatitis B Virus-Infected Mothers Ioannis Elefsiniotis, Miltos Papadakis, George Vlahos, Intervirology ImmunohematologyImmunologyHepatitis BMaternal ImmunizationViral Persistence	2009	20

Page 1